卵巢抑制:早期更年期,晚期影响
Chaya Goldberg1, Megan R Greenberg1, Alexandra Noveihed1
1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Current oncology reports
|February 2, 2024
概括
卵巢功能抑制 (OFS) 有助于绝经前妇女与激素受体乳腺癌,但导致显著的毒性. 管理这些副作用对于患者的福祉和治疗坚持至关重要.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 妇女健康 妇女健康
背景情况:
- 患有激素受体 (HR) 乳腺癌的绝经前妇女通常需要抑制卵巢功能 (OFS) 来降低雌激素水平并改善结果.
- 虽然OFS提供了疾病益处,但相关的毒性往往未得到报道,并且可以显著影响生活质量.
研究的目的:
- 对 HR 乳腺癌的绝经前妇女长期抑制卵巢功能 (OFS) 的毒性进行审查.
- 强调需要平衡OFS的好处与不良影响,并强调支持性护理策略.
主要方法:
- 本综述综合了关于OFS毒性的现有文献.
- 它分析了报告的副作用及其对患者遵守和长期健康结果的影响.
主要成果:
- OFS与心血管,骨和代谢疾病的风险增加有关.
- 常见的毒性包括血管运动症状,泌尿器缩,体重增加,性功能障碍,认知衰退和睡眠障碍.
- 这些毒性导致粘附不良,特别是在年轻的患者中.
结论:
- 在提出治疗建议时,提供者必须批判性地分析OFS的风险和益处.
- 综合性支持性护理对于管理多系统毒性和减轻对所有原因死亡率的长期影响至关重要.
- 未来的研究应该将患者报告的结果和症状管理策略与疾病结果评估相结合.
相关概念视频
Menopause
166
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
166
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Hormonal Control of the Ovarian Cycle
514
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
514
Hormonal Regulation of the Menstrual Cycle
391
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
391
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Disorders of the Female Reproductive System
363
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
363


